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Somatic mutations of the cohesin complex subunit STAG2 are present in diverse tumor
types. We and others have shown that STAG2 inactivation can lead to loss of sister chroma-
tid cohesion and alterations in chromosome copy number in experimental systems. How-
ever, studies of naturally occurring human tumors have demonstrated little, if any,
correlation between STAG2mutational status and aneuploidy, and have further shown that
STAG2-deficient tumors are often euploid. In an effort to provide insight into these discrep-
ancies, here we analyze the effect of tumor-derived STAG2mutations on the protein com-
position of cohesin and the expected mitotic phenotypes of STAG2mutation. We find that
many mutant STAG2 proteins retain their ability to interact with cohesin; however, the pres-
ence of mutant STAG2 resulted in a reduction in the ability of regulatory subunits WAPL,
PDS5A, and PDS5B to interact with the core cohesin ring. Using AAV-mediated gene tar-
geting, we then introduced nine tumor-derived mutations into the endogenous allele of
STAG2 in cultured human cells. While all nonsense mutations led to defects in sister chro-
matid cohesion and a subset induced anaphase defects, missense mutations behaved like
wild-type in these assays. Furthermore, only one of nine tumor-derived mutations tested
induced overt alterations in chromosome counts. These data indicate that not all tumor-
derived STAG2mutations confer defects in cohesion, chromosome segregation, and ploidy,
suggesting that there are likely to be other functional effects of STAG2 inactivation in human
cancer cells that are relevant to cancer pathogenesis.
Author Summary
Mutations of the STAG2 gene are common in several types of adult and pediatric cancers.
In fact, STAG2 is one of only 12 genes known to be significantly mutated in four of more
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types of cancer. The STAG2 gene encodes a protein component of the “cohesin complex,”
a ring-like structure that binds chromosomes together (e.g., “coheres” them) until the
cohesin complex is degraded during cell division, allowing replicated chromosomes to sep-
arate normally to the two new cells. The cohesin complex also plays important roles in
other cellular processes including turning genes on and off, and in repairing damaged
genes. Here we analyze the effect of cancer-causing mutations in STAG2 on its ability regu-
late the separation of chromosomes during cell division.
Introduction
Cohesin is a multiprotein complex comprised of four primary subunits (SMC1A, SMC3,
RAD21, and either STAG1 or STAG2) and four regulatory subunits (WAPL, CDCA5, and
PDS5A or PDS5B) that is responsible for sister chromatid cohesion, regulation of gene expres-
sion, DNA repair, and other phenotypes [1,2]. Somatic mutations of cohesin subunits are com-
mon in a wide range of pediatric and adult cancers [3,4]. STAG2 (also known as SA2) is the
most commonly mutated subunit, presumably in part because the STAG2 gene is located on
the X chromosome and therefore requires only a single mutational event to be inactivated [5].
Approximately 85% of tumor-derived STAG2mutations lead to premature truncation of the
encoded protein, whereas approximately ~15% are missense mutations.
STAG2mutations are particularly common in bladder cancer (present in 30–40% of the
most common non-muscle invasive tumors), Ewing sarcoma (present in ~25% of tumors), and
myeloid leukemia (present in ~8% of tumors), and are also present in glioblastoma multiforme
(GBM), melanoma, and other tumor types [6,7,8,9,10,11,12,13,14,15]. Highlighting the impor-
tance of STAG2 as a cancer gene, in 2014 The Cancer Genome Atlas identified STAG2 as one
of only 12 genes that are significantly mutated in four or more human cancer types (the others
were TP53, PIK3CA, PTEN, RB1, KRAS, NRAS, BRAF, CDKN2A, FBXW7, ARID1A and
KMT2D; [16]). Among the other components of cohesin, RAD21 is the most commonly
mutated subunit, with mutations of SMC1A and SMC3 also present in a subset of tumors. In
addition to the frequent mutations in human tumors, the role of STAG2 inactivation in cancer
pathogenesis is also highlighted by the fact that it is commonly altered in transposon-mediated
tumorigenesis in mouse model systems [17,18].
The mechanism(s) through which cohesin gene mutations confer a selective advantage to
cancer cells is controversial. In our initial studies identifying STAG2mutations in cancer, we
demonstrated using isogenic human cultured cell systems that STAG2mutations can lead to
alterations of chromosome counts and aneuploidy [5,6]. These findings were consistent with
other observations in yeast, mice, and other model systems indicating that mutations in cohe-
sin subunits lead to chromosomal non-disjunction and aneuploidy [19,20,21,22]. However,
more recent studies of naturally occurring human tumors have demonstrated either weak or
no correlations between the presence of cohesin gene mutations and aneuploidy [8]. Further-
more, a subset of naturally occurring human tumors harboring cohesin gene mutations are
euploid.
These conflicting data are likely in part attributable to the paucity of currently available
functional data on tumor-derived STAG2mutations. For example, our reported functional
studies of tumor-derived STAG2mutations have been primarily limited to two truncating
mutations present in the human H4 and 42MGBA GBM cell lines (which were corrected by
human somatic cell gene targeting). Others have demonstrated that myeloid leukemia cell lines
harboring specific cohesin gene mutations have reduced levels of chromatin-bound cohesin
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compared to non-isogenic myeloid leukemia cells harboring wild type cohesin genes [10].
These authors further showed that ectopic expression of wild-type STAG2 can lead to growth
suppression of myeloid leukemia cells harboring specific endogenous mutations of STAG2.
Other work has focused on the functional consequences of STAG2 depletion in mammalian
cells, without testing individual mutations. For example, it has recently been shown that tran-
sient depletion of STAG2 in human cells leads to a significant increase in errors in chromosome
segregation due to aberrant kinetochore-microtubule attachments [23]. Furthermore, we and
others have shown that stable depletion of STAG2 in bladder cancer cells leads to alterations in
chromosome counts [6,24].
Here we report a comprehensive analysis of the effects of tumor-derived STAG2mutations
on the composition of cohesin and on mitotic phenotypes generally attributed to cohesin inac-
tivation. We find that many mutant STAG2 proteins retain the ability to interact with cohesin,
but result in a generalized reduction in levels of core cohesin subunits and in the ability of
PDS5A, PDS5B, andWAPL to interact with the core cohesin ring. We then created and studied
isogenic sets of human cells in which the endogenous allele of STAG2 was modified via the
addition of nine different tumor-derived mutations. While all nonsense mutations led to abro-
gation of sister chromatid cohesion and some nonsense mutations led to anaphase defects,
tumor-derived missense mutations behaved like wild-type in these assays. Furthermore, few of
the cell lines demonstrated the expected alterations in chromosome counts.
Results
Ectopic expression of tumor-derived STAG2mutants in human cells
To express tumor-derived STAG2mutations in human cells, we created a full length human
STAG2 expression vector with a 1x FLAG/Streptavidin Binding Peptide (SBP) dual epitope tag
at the amino terminus. This human STAG2 expression vector corresponds to transcript
CCDS43990. This new cDNA expression vector differs from the STAG2 expression vector used
in previous studies (transcript CCDS14607), which was a naturally-occurring splice variant
missing the 37 amino acids encoded by exon 30. Transfection of the new, dual epitope-tagged
expression vector into 293T cells led to expression of the tagged STAG2 cDNA (Fig 1).
In naturally occurring human tumors, ~85% of STAG2mutations are truncating and ~15%
are missense, with mutations spread roughly evenly throughout the gene [3]. There is also a
minor mutational hotspot in Ewing sarcoma (R216X; ref. 13), found in ~20% of Ewing sar-
coma tumors harboring mutations of STAG2. To model these mutations, we used site-directed
mutagenesis to introduce 50 tumor-derived mutations into the cloned cDNA. The mutations
were derived from numerous tumor types and were spread evenly throughout the gene (Fig 1A
and S1 Table). These constructs were transfected into 293T cells, and their expression mea-
sured by Western blotting with FLAG antibodies. As depicted in Fig 1B, most of the truncating
mutations were expressed very poorly, possibly due to nonsense mediated decay of the encoded
transcript. Four missense mutations (#4,5,22,44) were expressed at levels equivalent to wild-
type protein.
Many tumor-derived mutant STAG2 proteins retain the ability to interact
with the cohesin complex
Arguably the most straightforward hypothesis regarding the loss of activity caused by tumor-
derived STAG2mutations is that the mutations abolish the ability of the encoded STAG2 pro-
tein to interact with the rest of the cohesin complex. To test this, we measured the interaction
of three missense mutations and two nonsense mutations with cohesin subunits SMC1A,
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SMC3, RAD21, STAG2, STAG1, WAPL, and PDS5A by immunoprecipitation (IP)—Western
blotting. As depicted in Fig 2, each of the three proteins encoded by STAG2 genes harboring
tumor-derived missense mutations retained its ability to interact with cohesin. Similarly, a
truncated protein encoded by a STAG2 gene harboring a tumor-derived late truncating muta-
tion (S1075X) also retained its ability to interact with cohesin. In contrast, the STAG2 protein
encoded by a gene with an earlier truncating mutation (S653X) lost the ability to interact with
the rest of the cohesin complex.
We next determined the boundary in STAG2 protein at which tumor-derived truncating
mutations retained their ability to interact with cohesin. To do this, we created nine additional
tumor-derived truncating mutations in STAG2 from amino acid 1021 to amino acid 1137 in
the cloned STAG2 expression vector (#51–59; Fig 3A, S1 Table), transfected 293T cells, and
performed IP-Western blotting. As depicted in Fig 3B, amino acids 983 to 1268 are dispensable
for the interaction with cohesin, corresponding roughly to the beginning of the regulatory
phosphorylation sites in the STAG2 protein [25]. These results are concordant with data from
the recently published crystal structure of STAG2, which shows that STAG2 interacts with
cohesin via an extensive interface with RAD21 that spans nearly the entire length of STAG2
and that is not disrupted by missense mutations targeting the interface [26]. Taken together,
Fig 1. Expression of tumor-derived mutations of STAG2 in human cells. (A) Mutations tested are depicted by arrows and described in detail in S1 Table.
Truncating mutations are in black, and missense mutations are in red. STAG, stromal antigen domain; SCD, stromal in conserved domain. Phosphorylation
sites are denoted by vertical bars. (B) 293T cells were transfected with wild-type and mutant epitope-tagged STAG2 expression vectors, harvested in 1%
NP40 lysis buffer, and their expression measured via immunoblotting with FLAG antibodies.
doi:10.1371/journal.pgen.1005865.g001
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these data demonstrate that tumor-derived mutations of STAG2 do not uniformly lose the abil-
ity to interact with cohesin, indicating that at least some tumor-derived mutations of STAG2
must affect a key function of STAG2 other than its ability to interact with cohesin.
Effects of STAG2mutations on the composition of cohesin
Having shown that many STAG2mutations do not abrogate the ability of STAG2 to interact
with cohesin (Figs 2 and 3), we next hypothesized that tumor-derived mutations in STAG2
might instead lead to generalized abnormalities in the subunit composition of the cohesin com-
plex itself. To test this, we studied previously described isogenic sets of H4 and 42MGBA GBM
cells in which the endogenous naturally occurring mutant allele of STAG2 were corrected by
somatic cell gene targeting [5]. Non-detergent nuclear lysates were prepared from these iso-
genic sets of cells, endogenous cohesin was immunoprecipitated using SMC3 antibodies, and
Western blot analysis performed using antibodies specific to the cohesin components SMC1A,
SMC3, RAD21, STAG1, STAG2, WAPL, PDS5A, and PDS5B.
Correction of the endogenous mutant allele of STAG2 led to an increase in total levels of the
core cohesin subunits SMC1A, SMC3, and RAD21 in both H4 and 42MGBA cells, but did not
affect the total levels of regulatory factors WAPL, PDS5A, or PDS5B (Fig 4A). Targeted correc-
tion of mutant STAG2 did not affect the ability of SMC3 to co-immunoprecipitate SMC1A,
SMC3, or RAD21 (Fig 4B; S1 Fig), demonstrating that STAG2 is not required for assembly of
the core cohesin ring. However, targeted correction of mutant STAG2 substantially enhanced
the ability of WAPL, and to a lesser extent PDS5A and PDS5B, to interact with cohesin (Fig
4B), consistent with recently published structural studies showing that STAG2 functions in
part as a structural scaffold for the interaction of WAPL with the core cohesin ring [27]. Taken
Fig 2. Interaction of mutant STAG2 proteins with cohesin. 293T cells were transfected with wild-type and
mutant STAG2 epitope tagged expression vectors and harvested in 1%NP40 lysis buffer. Immunoprecipitation
was performed with streptavidin beads, and immunoblotting was performed with the antibodies indicated.
Mutations tested include S97X, bladder cancer; V181M, myeloid leukemia; S202L, bladder cancer; Q593K,
bladder cancer; S653X, GBM; S1075X, bladder cancer.
doi:10.1371/journal.pgen.1005865.g002
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together, these data indicate that the presence of tumor-derived STAG2mutations results in a
decrease in levels of cohesin and a reduction in ability of WAPL, PDS5A, and PDS5B to inter-
act with cohesin.
Modelling of nine tumor-derived STAG2mutations in human cells by
AAV-mediated human somatic cell gene targeting
We next wanted to determine the functional significance of a representative subset of these
mutations in human cells. In an initial attempt to do this, we created several STAG2 expressing
lentiviruses for reconstituting wild-type and mutant STAG2 expression in cancer cells harbor-
ing STAG2mutations. However, we found that expression of STAG2 from these ectopic sys-
tems was inconsistent and substantially less than that expressed from the endogenous allele in
cells with wild-type STAG2.
To circumvent this, AAV-mediated human somatic cell gene targeting was used to “knock-
in” (KI) tumor-derived mutations into the endogenous allele of STAG2 in HCT116 cells, a
human cancer cell line with a single, wild-type allele of STAG2, intact sister chromatid cohe-
sion, and a near-diploid karyotype. Of note, we have previously used a similar approach to KI a
single, non-tumor derived amino terminal nonsense mutation at codon six into STAG2 in
Fig 3. Identification of the boundary for interaction of STAG2 with cohesin. The mutations tested are depicted in (A) and described in detail in S1 Table.
STAG, stromal antigen domain; SCD, stromal in conserved domain. Phosphorylation sites are denoted by vertical bars. (B) 293T cells were transfected with
wild-type and mutant epitope tagged expression vectors and harvested in 1% NP40 lysis buffer. Immunoprecipitation was performed with streptavidin beads,
and immunoblotting was performed with the antibodies indicated.
doi:10.1371/journal.pgen.1005865.g003
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HCT116 cells and demonstrated a substantial reduction in sister chromatid cohesion and alter-
ations in chromosome counts [5].
To do this, we created nine AAV-based targeting vectors in the pAAV-SEPT vector system
and used these vectors to create clonal derivatives of HCT116 cells in which the single endoge-
nous allele of STAG2 had been mutated (Fig 5A–5C). The details of this approach are described
in Materials and Methods. Targeting efficiencies were 14–29% (S2 Table). Western blot analy-
sis with a monoclonal antibody recognizing the carboxyl terminus of STAG2 demonstrated
that, as expected, cells harboring the seven nonsense mutations completely lacked expression
of the c-terminal epitope (Fig 5D). In contrast, the two missense mutations were expressed at
levels equivalent to wild-type STAG2. Western blotting with an antibody recognizing the
amino terminus of STAG2 further demonstrated that the truncated proteins were expressed
poorly, concordant with the ectopic expression data shown in Fig 1 and consistent with the
notion that the transcripts may have been degraded via nonsense-mediated decay.
Effects of endogenous STAG2mutations on cellular proliferation
To determine whether the introduction of tumor-derived mutations had an effect on the prolif-
eration of HCT116 cells, in vitro cellular proliferation assays were performed on the isogenic
Fig 4. Cohesin subunit composition in STAG2mutant human cancer cells. (A) Nuclear lysates derived
from isogenic STAG2mutant (MUT) and corrected (WT) H4 and 42MGBAGBM cells were studied by
Western blot using the antibodies indicated. (B) Nuclear lysates used in (A) were subjected to
immunoprecipitation using SMC3 antibodies andWestern blots performed with the antibodies indicated. The
complete blot with all negative control lanes included is shown in S1 Fig. For both (A) and (B) bands were
quantified using ImageJ software, and fold increase compared to isogenic STAG2mutant parental cells is
indicated below the relevant bands. The results depicted represent a trend that was consistent in four
independently-derived clones representing two unrelated sets of isogenic STAG2mutant and wild-type cell
lines.
doi:10.1371/journal.pgen.1005865.g004
Intact Cohesion, Anaphase, and Chromosome Segregation in STAG2Mutant Human Cells
PLOS Genetics | DOI:10.1371/journal.pgen.1005865 February 12, 2016 7 / 18
sets of cells. As shown in Fig 6A, mutation of STAG2 had a slightly adverse effect on the prolif-
eration of HCT116 cells. To confirm and extend this result, we performed similar assays on
two isogenic sets of GBM cells (42MGBA, H4) in which the endogenous mutant allele of
STAG2 had been corrected by gene targeting. As predicted by the result in the HCT116 cell
lines, in both H4 cells and 42MGBA cells, correction of STAG2 led to slightly enhanced prolif-
eration (Fig 6B and 6C). Taken together, these data suggest that unlike in the case of most
tumor suppressor genes, mutational inactivation of STAG2may have an adverse effect on
proliferation.
Effects of nonsense and missense mutations in STAG2 on sister
chromatid cohesion in human cells
To measure the effects of tumor-derived nonsense and missense mutations on sister chromatid
cohesion, we enriched the HCT116 cells and STAG2 KI derivatives in mitosis by short treat-
ment with nocodazole, then examined prometaphase chromosome spreads to analyze sister
chromatid cohesion. For details, see Materials and Methods. As shown in Fig 7, all tumor-
derived nonsense mutations in STAG2 led to a reduction in the integrity of sister chromatid
cohesion. In contrast, tumor-derived missense mutations displayed wild-type sister chromatid
cohesion. These data suggest either that STAG2 nonsense mutations have a different patho-
genic mechanism than STAG2missense mutations, or that abrogation of sister chromatid
cohesion is not the key property targeted by tumor-derived mutations in STAG2.
Fig 5. Knockin (KI) of tumor-derived STAG2mutations into near-diploid, chromosomally stable cultured human cells. (A) The nine mutations
introduced into HCT116 cells. (B) Schematic of AAV-based KI vector for KI of tumor-derived mutations into the endogenous allele of STAG2. (C)
Representative sequencing traces of parental and KI cells for two of the mutations after targeted integration. (D) STAG2Western blot for parental and KI cells
using antibodies specific to the amino terminus and carboxyl terminus of the STAG2 protein.
doi:10.1371/journal.pgen.1005865.g005
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Effects of nonsense and missense mutations in STAG2 on anaphase
integrity in human cells
Next, we tested whether cells harboring tumor-derived mutations in STAG2 showed a reduc-
tion in the integrity of sister chromatid segregation during anaphase. To do this, proliferating
cells were fixed, triple stained with DAPI and antibodies to α-tubulin and the centromere
(ACA), and the fractions of anaphase cells with chromosome missegregation errors was deter-
mined (for details, see Materials and Methods). Three of seven cell lines harboring STAG2
truncating mutations (S653X, S1075X, and S1215X) had a statistically significant increase in
lagging chromosomes compared to isogenic cells with wild-type STAG2 (Fig 8; S3 Table).
There was no statistically significant increase in the fractions of cells with DNA bridges, acen-
tric fragments, or multipolar anaphases in any of the STAG2mutant cells (S3 Table).
Effects of nonsense and missense mutations in STAG2 on chromosome
counts in human cells
In two previous studies, we found that introduction of a non-tumor derived mutation or stable
lentiviral depletion of wild-type STAG2 led to alterations in chromosome counts in human
Fig 6. Proliferation assays of isogenic STAG2wild-type andmutant cell lines. Cell proliferation was measured using the Cell Titre Glo assay for (A)
HCT116 cells and KI derivatives harboring tumor-derived mutations of STAG2, (B) H4 cells (MUT) and STAG2-corrected derivatives (WT), and (C) 42MGBA
cells (MUT) and STAG2-corrected derivatives (WT). Though the differences in proliferation between isogenic STAG2wild-type and mutant cells were subtle
and did not reach p<0.05, the observation that STAG2 wild-type cells proliferate more quickly than otherwise isogenic STAG2mutant cells was a trend that
was seen in three different isogenic sets of cell lines (shown in A, B, and C), and in each case seen in multiple independently-derived gene targeted clones.
doi:10.1371/journal.pgen.1005865.g006
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cells–in both cases increasing the modal chromosome number by one [5,6]. To determine if
similar results would be obtained after introduction of tumor-derived mutations into STAG2,
chromosomes were counted in parental HCT116 cells and derivatives with each of the nine
tumor-derived mutations. As described in Materials and Methods, prometaphase chromosome
spreads were prepared, and the number of chromosomes in 100 cells was determined for each
cell line. Surprisingly, there was no change in modal chromosome number after introduction
of eight of the tumor-derived mutations, with the exception of the introduction of S653X,
which led to an increase in the modal chromosome number by one (Table 1). This experiment
indicates that many tumor-derived mutations in STAG2 do not have an overt effect on chro-
mosome count when introduced into HCT116 cells.
Discussion
Somatic mutations of genes encoding components of the cohesin complex are common in a
variety of adult and pediatric human cancers. The most commonly mutated cohesin gene is
Fig 7. Sister chromatid cohesion assays.HCT116 cells and STAG2mutant derivatives were enriched in
prometaphase by brief treatment with nocodazole, and chromosome spreads were prepared and analyzed
by light microscopy (100X objective) to determine whether mutations led to aberrations in cohesion.
Examples are shown in (A), and quantification is shown in (B). A cell was determined to have loss of cohesion
if three or more sister chromatids were parallel. 100 prometaphases were counted per cell line. Counting was
performed in a blinded fashion. The differences in numbers of parallel sister chromatids between parental
STAG2wild-type cells and derivatives with truncating mutations of STAG2were significant (*, p<0.05).
doi:10.1371/journal.pgen.1005865.g007
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STAG2, with other cohesin genes such as RAD21, SMC1A and SMC3 also mutated in a subset
of tumors. Now that the frequencies and tumor-type specificities of these mutations have been
established, it has become increasingly important to determine the functional role played by
these mutations in tumorigenesis. In the studies presented here we have focused our attention
on the role of tumor-derived mutations in STAG2 on the protein composition of cohesin, cellu-
lar proliferation, mitosis, and aneuploidy.
Arguably the most straightforward hypotheses regarding the loss of function caused by
tumor-derived STAG2mutations is that the mutations either abolish the ability of STAG2 to
interact with the rest of the cohesin complex, or that they lead to more generalized
Fig 8. Chromosome segregation during anaphase in STAG2mutant cells. Proliferating HCT116 cells and STAG2mutant derivatives were triple stained
using DAPI and using antibodies to the centromere (ACA) and microtubules (α-tubulin). PC-1 cells are an HCT116 clone with random integration of an AAV
targeting vector, and serve as an additional negative control. Anaphase cells were identified and lagging chromosomes and multipolar mitoses were counted.
Examples of lagging chromosomes are shown in (A), and quantification is shown in (B). Cells harboring the S653X, S1075X, and S1215Xmutations had a
statistically significant increase (*, p<0.05) in lagging chromosomes. For raw data, see S3 Table.
doi:10.1371/journal.pgen.1005865.g008
Table 1. Chromosome counts in parental and STAG2mutant HCT116 cells.
HCT116 PC-1 PC-2 PC-3 S97X S653X I885fs S1075X Q1117X Y1142fs S1215X V181M S202L
39 2
40 1 1 1
41 1 2
42 1 1 3
43 1 4 4 5
44 4 4 12 12 6 1 6 28 12 11 2 2 2
45 70* 78* 63* 73* 56* 7 74* 53* 60* 63* 81* 73* 78*
46 22 18 16 11 38 92* 16 11 21 26 17 25 19
47 3 1 2 2 1 1
Chromosomes were counted in 100 prometaphase cells for each cell line. PC-1, PC-2, and PC-3 are three independently derived control clones with
random integration of the KI vector. Modal chromosome numbers are indicated with asterisk.
doi:10.1371/journal.pgen.1005865.t001
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abnormalities in the subunit composition of cohesin. To test these hypotheses, we expressed 59
tumor-derived mutations in human cells in an epitope tagged STAG2 cDNA. Many of the
mutations led to virtually complete loss of expression of the encoded protein, consistent with
the expectation that STAG2 genes harboring tumor-derived nonsense mutations produce tran-
scripts that are degraded by nonsense mediated decay. We then performed IP-Western blot
analyses on the mutant STAG2 proteins that were expressed, and showed that many tumor-
derived mutations do not abolish the ability of the encoded protein to interact with cohesin.
These data indicate that the ability to interact with the rest of the cohesin complex is not—or at
least not the only—key property of STAG2 abrogated by tumor-derived mutations in the gene.
We then tested an alternate hypothesis—that STAG2mutations cause alterations in the
amount and/or subunit composition of cohesin in human cancer cells. We found that cells har-
boring STAG2mutations have roughly half as much SMC1A, SMC3, and RAD21 as otherwise
isogenic cells with wild-type STAG2. This result is consistent with previous studies showing
that myeloid leukemias with STAG2mutations have less chromatin-bound cohesin than leuke-
mias with wild-type STAG2 [10]. Our result suggests that this may have been due to a reduc-
tion in cohesin itself rather than a reduction in the efficiency by which cohesin binds
chromatin.
Next, we tested the hypothesis that mutations in STAG2 result in alterations in the subunit
composition of cohesin. We found that STAG2mutations did not affect the composition of the
core cohesin ring (composed of SMC1A, SMC3, RAD21, and STAG1 or STAG2). However,
the presence of a STAG2mutation did adversely affect the ability of cohesin regulatory factor
WAPL (and to a lesser extent PDS5A and PDS5B) to interact with the core cohesin ring. These
results are consistent with current models of cohesin structure, which suggest that STAG2 is
not itself a key structural scaffold for assembly of the core cohesin ring, but instead is tethered
to cohesin via its interaction with RAD21. Furthermore, our finding that interaction of WAPL
with cohesin depends in part on STAG2 is in agreement with recently published structural
studies showing that STAG2 functions as a structural scaffold for the interaction of WAPL
with the core cohesin ring [27]. Of note, WAPL is required for removal of cohesin from chro-
mosome arms during prophase, and reductions in cohesin-boundWAPL have previously been
shown to lead chromosomal non-disjunction and aneuploidy [28].
Next, we used human somatic cell gene targeting to introduce a subset of these tumor-
derived mutations into the endogenous allele of STAG2 in a chromosomally stable, near diploid
human cell line. Despite the fact that only 14% of tumor-derived mutations in STAG2 are mis-
sense (the remainder are truncating), we intentionally introduced several missense mutations
since we believe their effects are likely to be more subtle and therefore could shed important
light on the specific functional deficiencies of STAG2 in cancer. Interestingly, genetically modi-
fied cells harboring STAG2mutations proliferated slightly more slowly than isogenic parental
cells with wild-type STAG2 –a result which was then confirmed by measuring the proliferation
of several additional isogenic sets of GBM cells in which the endogenous mutant allele of
STAG2 had been corrected by human somatic cell gene targeting.
This observation that endogenous STAG2mutations slow cellular proliferation is surprising,
since mutations in tumor suppressor genes are generally thought to enhance cellular prolifera-
tion. Of note, our proliferation data are in disagreement with recent results from Balbas-Marti-
nez et al. and Kon et al., who showed that ectopic re-expression of wild-type STAG2 and
RAD21 in cancer cells harboring endogenous mutations of those genes leads to suppression of
proliferation [8,10]. It is possible that the discrepancies between our data and those of Balbas-
Martinez and Kon et al. are due to differences between ectopic and endogenous expression of
wild-type STAG2 and/or cell type specific differences.
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Using these isogenic sets of cells, we next tested the effect of tumor-derived nonsense and
missense mutations in STAG2 on sister chromatid cohesion, mitotic fidelity, and chromosome
counts. As expected based on our previous studies, all seven nonsense mutations in STAG2 led
to substantial reductions in the integrity of sister chromatid cohesion during metaphase. How-
ever, to our surprise, tumor-derived missense mutations retained wild-type levels of sister
chromatid cohesion. Furthermore, only a subset of the nonsense mutations (and none of the
missense mutations) caused an increase in lagging chromosomes during anaphase, generally
considered a marker of chromosomal instability. Furthermore, despite the substantial defects
in cohesion in cells with STAG2 nonsense mutations (and the increase in lagging chromosomes
in a subset of the cell lines), only one of the mutant STAG2 KI cell lines demonstrated alter-
ations in chromosome counts when compared to isogenic cells with wild-type STAG2 genes.
These results raise a number of interesting issues and questions regarding the role of STAG2
gene mutations in cancer pathogenesis. First, we believe that the study of tumor-derived mis-
sense mutations provides a particularly useful window into the specific functions of STAG2
that are relevant to cancer pathogenesis, since the adverse effects of missense mutations are
likely to more specific to cancer pathogenesis than the more pleiotropic effects of early truncat-
ing mutations (with the caveat that it is a formal possibility that a subset of missense mutations
are passenger mutations). The fact that the missense mutations tested retained wild-type cohe-
sion, mitotic integrity, and ploidy suggests that perhaps these phenotypes are not central to the
cancer-causing effects of STAG2mutations. Such an interpretation could help resolve a funda-
mental current discrepancy in the field–that all tumor-derived mutations tested so far (all of
which have been truncating mutations) result in dramatic reductions in cohesion, and yet
many naturally occurring tumors with STAG2mutations appear to be euploid. Alternatively, it
is a formal possibility that nonsense and missense mutations in STAG2 lead to deficiencies in
two different functions of STAG2 and therefore lead to cellular transformation through two
different pathways. However, we consider this possibility to be unlikely.
The chromosome counting data presented here are especially surprising in light of our pre-
viously published data showing that the introduction of an amino terminal, non-tumor derived
truncating mutation into STAG2 leads to an increase in modal chromosome number [5]. Simi-
lar results were also obtained in a bladder cancer cell line with shRNA-mediated depletion of
STAG2 [6]. It is particularly surprising that only one of the seven nonsense mutations tested
resulted in an alteration in chromosome count, despite the fact that all nonsense mutations led
to substantial reductions in sister chromatid cohesion and a subset led to an increase in lagging
chromosomes during anaphase. Though surprising in light of the preponderance of published
data on the relationship of cohesion to aneuploidy, these data are consistent with published
work in Saccharomyces cerevisiae suggesting that low levels of cohesin can be sufficient to
maintain euploidy [29,30]. When taken together with the results presented for the missense
mutations tested, these results further call into question whether the cancer relevant pheno-
types of STAG2mutations are directly related to cohesion and aneuploidy.
In summary, here we analyze the properties of a substantial number of tumor-derived muta-
tions in STAG2. In addition to evaluating the effect of the mutations on the composition of
cohesin, we demonstrate that the mutations do not uniformly abrogate sister chromatid cohe-
sion, anaphase integrity, or the ability of the cells to control their ploidy. These data suggest
either that different mutations of STAG2 have different mechanisms through which they cause
cancer, or that the specific mechanism(s) through which STAG2 and other cohesin gene muta-
tions contribute to cancer pathogenesis remain, at present, unknown.
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Materials and Methods
Human STAG2 expression vector
A human STAG2 cDNA (CCDS43990) with an amino terminus 1X FLAG/SBP dual epitope
tag was synthesized de novo by Genscript and cloned into pUC57. Tumor-derived mutations
were created by site-directed mutagenesis using the QuikChange II XL kit (Stratagene) as
directed by the manufacturer. Wild-type and mutant cDNAs were then subcloned into
pcDNA3.1.
Cell culture
HCT116 cells were obtained from ATCC. H4 and 42MGBA parental cells and gene targeted
derivatives in which the endogenous mutant allele of STAG2 was corrected by AAV-mediated
human somatic cell gene targeting were described previously [5].
Antibodies
Primary antibodies for immunoblotting were FLAG (M2) from Sigma Aldrich; STAG2 (J-12;
carboxyl-terminus epitope), STAG1 (A-9), RAD21 (B-2), SMC3 (E-3), SMC1A (M-16), WAPL
(A-7), and PDS5A (S-20) from Santa Cruz Biotechnology; and PDS5B (A300-537A) and
STAG2 (A302-580A; amino terminus epitope) from Bethyl Laboratories. Antibodies and con-
jugated beads for immunoprecipitation were FLAG-M2 beads from Sigma Aldrich, SMC3
(A300-060A) from Bethyl Laboratories, and Streptavidin Plus UltraLink Resin from Pierce.
Antibodies for immunofluorescence were anti-centromere antibody (ACA) from Geisel School
of Medicine, α-tubulin (DM1α) from Sigma Aldrich, and Alexa Fluor 488 and 568 from
Molecular Probes.
Immunoprecipitation and western blot
Protein lysates for direct Western blotting were prepared in NP40 lysis buffer (50 mM Tris-
HCl pH 7.5, 150 mMNaCl, 1% NP40). Nuclear lysates used for affinity purification were pre-
pared using a modification of Dignam's nondetergent lysis method [31]. Protein concentra-
tions were determined using the bicinchoninic assay (Pierce). For affinity purification of
proteins tagged with Streptavidin Binding Peptide (SBP), streptavidin beads (Pierce) were
washed once with Tris-buffered saline (TBS; 150 mMNaCl) and then incubated with protein
lysates derived from cells transfected with constructs expressing epitope-tagged proteins. Sam-
ples were incubated with rotation at 4°C for 1 h. Beads were then washed three times with TBS,
and bound proteins eluted by boiling in sample buffer, separated by SDS-PAGE, and Western
blot analysis performed.
AAV-mediated human somatic cell gene targeting
Homology arms (~1 kb each) for creation of STAG2 KI vectors were synthesized by Genscript
and cloned into the pAAV-SEPT-Acceptor vector [32]. Next, transient stocks of AAV-2 virions
were created by co-transfection of 293T cells with STAG2 KI vectors together with pAAV-RC
(Stratagene) and pHELPER (Stratagene) using X-tremeGENE 9 (Roche). Two days after trans-
fection, media was aspirated and cell monolayers were scraped into 1 mL PBS and subjected to
four cycles of freeze/thaw. The lysate was then clarified by centrifugation at 12,000 rpm for 10
min in a benchtop microfuge to remove cell debris, and the virus-containing supernatant was
aliquoted and stored at −80°C. 200 μL of virus was then used to infect HCT116 cells in T25 tis-
sue culture flask, and cells were passaged at limiting dilution into 96-well plates in the presence
of 1.0 mg/mL G418. Individual G418-resistant clones were expanded and used for the
Intact Cohesion, Anaphase, and Chromosome Segregation in STAG2Mutant Human Cells
PLOS Genetics | DOI:10.1371/journal.pgen.1005865 February 12, 2016 14 / 18
preparation of genomic DNA. Clones were tested for homologous integration of the targeting
vector using a primer pair specific for the targeted allele, and integration of the targeted muta-
tion was confirmed by DNA sequencing. For missense mutations, KI cells were then infected
with a Cre-expressing adenovirus to remove the FLOXed splice acceptor-IRES-neoR gene.
Proliferation assays
Cells were seeded at either 500 or 1000 cells/well in 96 well plates and cell number measured
every 48 hours using the Cell Titre Glo Assay (Promega).
Sister chromatid cohesion assay
Cells were grown to approximately 80% confluence, then treated with 330 μM nocodazole for
one hour. Cells were then harvested by trypsinization and hypotonically swollen in 40%
medium/60% Vienna tap water for 5 min at room temperature. Cells were fixed with freshly
made Carnoy’s solution (75% methanol, 25% acetic acid), and the fixative was changed several
times. For spreading, cells in Carnoy’s solution were dropped onto glass slides and dried at
37C. Slides were stained with 5% Giemsa at pH 6.8 for 7 min, washed briefly in tap water, air
dried, and mounted with Entellan mounting medium. Each experiment was performed inde-
pendently twice.
Immunofluorescence and image processing
Cells were fixed with 3.5% paraformaldehyde (Alfa Aesar) for 10 min, washed with Tris-buff-
ered saline with 5% bovine serum albumin (TBS-BSA) and 0.5% Triton X-100 for 2 x 5 min
with vigorous shaking and then rinsed in TBS-BSA. Primary antibodies were diluted in
TBS-BSA containing 0.1% Triton X-100 and incubated for 1–3 h at room temperature. Cells
were then washed with TBS-BSA/0.1% Triton X-100 for 3 x 10 min with vigorous shaking. Sec-
ondary antibodies were diluted in TBS-BSA plus 0.1% Triton X-100 and coverslips were incu-
bated for 1–2 h at room temperature. Cells were then washed with TBS-BSA containing 0.1%
Triton X-100 with DAPI for 3 x 10 min with vigorous shaking and then mounted using Pro-
Long Gold antifade reagent (Molecular Probes). Images were acquired with a cooled charge-
coupled device camera (Andor Technology, Belfast, UK) mounted on a Nikon Eclipse Ti
microscope (Nikon, Melville, NY) with a 60X, 1.4 numerical aperture objective. Image series in
the z-axis were obtained using 0.2-μm optical sections. Image deconvolution and contrast
enhancement was performed using AutoQuant X3 (Media Cybernetics), Elements software
(Nikon), Image J and Adobe Photoshop software. Final images represent selected overlaid
planes.
For quantifications of anaphase segregation defects, chromatids were counted as lagging if
they contained centromere staining (using ACA) or acentric if they did not contain centromere
staining, in the spindle midzone separated from centromeres/kinetochores at the poles. DNA
bridges were counted when a piece of stretched DNA (visualized by DAPI staining) spanned
the area between the two newly formed daughter nuclei in anaphase and no centromere stain-
ing was evident. Tripolar anaphases were counted when three clear chromosome populations
(with centromere staining) were evident in anaphase. For quantification of anaphase chromo-
some missegregation rates, no fewer than 150 anaphases per cell line were quantified. Statistical
analysis for anaphase chromosome missegregation rates was performed using Fisher’s exact
two-tailed test.
Intact Cohesion, Anaphase, and Chromosome Segregation in STAG2Mutant Human Cells
PLOS Genetics | DOI:10.1371/journal.pgen.1005865 February 12, 2016 15 / 18
Chromosome counting
Cultured cells were treated with 0.02 μg/ml colcemid for 45 minutes at 37°C. The cells were
then trypsinized, centrifuged at 200 x g, and the cell pellet resuspended in warmed hypotonic
solution and incubated at 37°C for 11 minutes. The swollen cells were then centrifuged and the
pellet resuspended in 8 mL of Carnoy’s fixative (3:1 methanol:glacial acetic acid). After incuba-
tion in fixative at room temperature for 22 minutes, the cell suspension was centrifuged and
washed twice in Carnoy’s fixative. After the last centrifugation, the cells were resuspended in 1
to 3 mL freshly prepared fixative to produce an opalescent cell suspension. Drops of the final
cell suspension were placed on clean slides and air-dried. Slides were stained with a 1:3 mixture
of Wright’s stain and 60 mM phosphate buffer for 4–10 minutes, washed with tap water for 5
seconds, and then air-dried. Chromosomes were counted in 100 prometaphases per cell line.
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